Axecap Investments LLC bought a new position in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 173,016 shares of the company's stock, valued at approximately $3,696,000. Phibro Animal Health accounts for approximately 3.1% of Axecap Investments LLC's portfolio, making the stock its 8th largest holding. Axecap Investments LLC owned approximately 0.43% of Phibro Animal Health at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in Phibro Animal Health by 1.4% in the 4th quarter. Vanguard Group Inc. now owns 1,514,736 shares of the company's stock worth $31,809,000 after purchasing an additional 20,604 shares in the last quarter. American Century Companies Inc. increased its stake in Phibro Animal Health by 18.0% in the 4th quarter. American Century Companies Inc. now owns 635,599 shares of the company's stock worth $13,348,000 after purchasing an additional 96,787 shares in the last quarter. Nuveen Asset Management LLC increased its stake in Phibro Animal Health by 21.4% in the 4th quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company's stock worth $12,348,000 after purchasing an additional 103,618 shares in the last quarter. Renaissance Technologies LLC increased its stake in Phibro Animal Health by 1.9% in the 4th quarter. Renaissance Technologies LLC now owns 557,800 shares of the company's stock worth $11,714,000 after purchasing an additional 10,600 shares in the last quarter. Finally, Geode Capital Management LLC increased its stake in Phibro Animal Health by 1.7% in the 4th quarter. Geode Capital Management LLC now owns 515,979 shares of the company's stock worth $10,838,000 after purchasing an additional 8,510 shares in the last quarter. 99.34% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of brokerages have commented on PAHC. Morgan Stanley raised their price objective on Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a research report on Thursday, May 8th. Wall Street Zen upgraded Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $20.00.
View Our Latest Stock Report on Phibro Animal Health
Phibro Animal Health Stock Down 2.4%
NASDAQ PAHC traded down $0.58 during trading on Friday, reaching $23.93. 152,026 shares of the company's stock were exchanged, compared to its average volume of 205,137. The firm has a market capitalization of $969.98 million, a PE ratio of 49.85, a P/E/G ratio of 0.45 and a beta of 0.74. The company has a current ratio of 3.20, a quick ratio of 1.37 and a debt-to-equity ratio of 2.99. Phibro Animal Health Co. has a fifty-two week low of $16.16 and a fifty-two week high of $26.55. The company's fifty day simple moving average is $21.25 and its 200-day simple moving average is $21.89.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.11. The business had revenue of $347.80 million during the quarter, compared to analyst estimates of $352.41 million. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Sell-side analysts predict that Phibro Animal Health Co. will post 1.95 EPS for the current year.
Phibro Animal Health Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be issued a dividend of $0.12 per share. The ex-dividend date is Wednesday, June 4th. This represents a $0.48 annualized dividend and a dividend yield of 2.01%. Phibro Animal Health's dividend payout ratio is 61.54%.
About Phibro Animal Health
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
See Also
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
